Direct SLT for Pseudoexfoliation Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a treatment called Direct Selective Laser Trabeculoplasty, which aims to help people with pseudoexfoliation glaucoma, a type of eye disease that causes high pressure and optic nerve damage. The main goal is to determine if this laser treatment can effectively lower eye pressure and improve outcomes for those affected. Suitable participants are adults diagnosed with pseudoexfoliation glaucoma who have not received similar treatments and have a specific level of vision and field loss in the eye being studied. As an unphased trial, this study offers participants the chance to contribute to valuable research that could lead to new insights and advancements in treating pseudoexfoliation glaucoma.
Will I have to stop taking my current medications?
The trial requires participants to stop taking their current medications for a period of time before starting the study, known as a 'washout period' (time without taking certain medications).
What prior data suggests that Direct Selective Laser Trabeculoplasty is safe for patients with pseudoexfoliative glaucoma?
A previous study found selective laser trabeculoplasty (SLT) to be generally safe. Reports indicated a few side effects, such as mild eye irritation, but these were uncommon. Another study examined SLT's long-term use and found it to be quite safe, with low rates of serious issues. Experts describe Direct Selective Laser Trabeculoplasty (DSLT) as a newer form of this treatment. While researchers continue to study DSLT, it is expected to have a safety profile similar to SLT, suggesting that most people tolerate it well.12345
Why are researchers excited about this trial?
Direct Selective Laser Trabeculoplasty (DSLT) is unique because it uses a laser to target and improve the drainage of fluid in the eye, specifically for those with Pseudoexfoliation Syndrome. Unlike traditional treatments that often rely on eye drops or more invasive surgeries, DSLT offers a non-invasive approach that can be performed quickly and with minimal discomfort. Researchers are excited about DSLT because it holds the promise of reducing eye pressure effectively with fewer side effects and less frequent follow-up treatments compared to current options.
What evidence suggests that Direct Selective Laser Trabeculoplasty is effective for pseudoexfoliative glaucoma?
Research shows that Direct Selective Laser Trabeculoplasty (DSLT), which participants in this trial will receive, effectively treats glaucoma. Studies have found that DSLT safely lowers intraocular pressure, crucial for managing glaucoma. The LiGHT trial discovered that this method serves as a good first choice for treating open-angle glaucoma and high eye pressure. Additionally, real-world data indicates that individuals with higher initial eye pressure often experience more significant pressure reductions after DSLT treatment. This suggests DSLT could be particularly beneficial for those with pseudoexfoliative glaucoma, where eye pressure is a major concern.12678
Are You a Good Fit for This Trial?
This trial is for adults with pseudoexfoliation glaucoma, a specific eye condition. Participants should have an open angle in their eye, not previously treated or able to stop current treatments, and must have relatively good vision (20/40 or better) and be capable of completing visual field tests.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Direct SLT (DSLT) treatment for pseudoexfoliative glaucoma
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Direct Selective Laser Trabeculoplasty
Trial Overview
The study is testing Direct Selective Laser Trabeculoplasty (DSLT), a laser treatment for lowering eye pressure in patients with pseudoexfoliation glaucoma. It's a forward-looking study across multiple centers where all participants receive the same intervention.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients treated with DSLT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vance Thompson Vision
Lead Sponsor
Citations
Real-world outcomes of selective laser trabeculoplasty ... - PMC
Pearson correlation analysis revealed a moderate correlation (r = -0.4021, p < 0.001) between higher baseline IOP and greater IOP reduction.
The Safety and Efficacy of Direct SLT in Pseudoexfoliation ...
A type of clinical study in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes.
Predictors of Selective Laser Trabeculoplasty Efficacy ...
Patients were randomized to one of four SLT variants, differing in treatment extent (180° or 360°) and laser power (standard or high).
Predictors of Selective Laser Trabeculoplasty Efficacy
Patients were randomized to one of 4 SLT variants, differing in treatment extent (180° or 360°), and laser power (standard or high).
Short-term results of direct laser trabeculoplasty (DSLT) in ...
The LiGHT trial reported that SLT is a safe and effective technique as a first-line treatment for open angle glaucoma and ocular hypertension.
What is the long-term efficacy and safety of selective laser ...
Primary outcomes included long-term IOP reduction and SLT failure rates. Secondary outcomes included medication use, visual field changes, and adverse events.
An Early Look at the New DSLT Technology
The next step in selective laser trabeculoplasty recently hit the market. Experts discuss what is and isn't yet known about direct laser ...
Full article: Long-term safety and efficacy of selective laser ...
Purpose. To investigate the safety and efficacy of selective laser trabeculoplasty (SLT) to reduce intraocular pressure (IOP) in patients with ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.